Home LiteratureArticle Details
PMID: 16261399 Published · ppublish English Comparative Study Journal Article

Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.

Breast cancer research and treatment ·Vol. 95 ·No. 2 ·2006-01-00 ·Pages 105-9

Gronwald J, Byrski T, Huzarski T, Cybulski C, Sun P, Tulman A, Narod SA, Lubinski J

Abstract

It has been estimated that the lifetime risk of breast cancer among women who inherit a BRCA1 or BRCA2 mutation is as high as 80%, and the risk estimates for ovarian cancer range from 15 to 40%. Several environmental and lifestyle factors are believed to contribute to the development of breast cancer in the general population and it is of interest to establish if these factors operate among mutation carriers as well. To evaluate the effects of age of menarche, parity, breast-feeding, oophorectomy and oral contraceptive use, as well as smoking and coffee consumption, on the risks of breast and ovarian cancer, we conducted a matched case-control study of Polish women with BRCA1 mutations. There were 348 breast cancer patients, 150 ovarian cancer patients and similar numbers of age-matched controls. BRCA1 carriers with late age of menarche, lower parity and long-term breast-feeding were less likely to develop breast cancer. Oral contraceptives protected against ovarian cancer.

MeSH Terms
Adolescent Adult Aged Breast Neoplasms/genetics,prevention & control Case-Control Studies Child Contraceptives, Oral/therapeutic use Female Genes, BRCA1 Germ-Line Mutation Heterozygote Humans Life Style Middle Aged Mutation Ovarian Neoplasms/genetics,prevention & control Parity Pregnancy Risk Factors
Chemicals
Contraceptives, Oral
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gronwald Jacek
International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. jgron@uoo.univ.szczecin.pl
Byrski Tomasz
Huzarski Tomasz
Cybulski Cezary
Sun Ping
Tulman Anna
Narod Steven A
Lubinski Jan
Article Info
Journal
Breast cancer research and treatment
Abbr.
Breast Cancer Res Treat
ISSN
0167-6806
Published
2006-01-00
Pages
105-9
Language
English
Region
Netherlands
NLM ID
8111104
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com